ARROW Pharma has announced the launch of a generic version of Xenical into the Australian market.
Prolistat contains orlistat as its active ingredient, and is indicated to help patients with weight management.
Arrow Pharma estimated the weight loss market for Australian pharmacies is worth $37.3 million, with the introduction of the generic version of orlistat set to provide "a significant cost-saving for consumers".
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Aug 17